An Intervention Program to Control Diabetes
1 other identifier
interventional
150
1 country
1
Brief Summary
Study to evaluate the effectiveness of a structured intervention to improve diabetes control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 12, 2007
CompletedFirst Posted
Study publicly available on registry
October 15, 2007
CompletedOctober 15, 2007
October 1, 2007
October 12, 2007
October 12, 2007
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c, Fasting blood glucose,blood pressure, weight loss
24 weeks
Interventions
Eligibility Criteria
You may qualify if:
- informed consent
- adults
- Type 2 Diabetes
- Males and non-pregnant females
You may not qualify if:
- Use of exogenous insulin for glucose control
- Use of medications or supplements for weight loss
- Advanced diabetes complications
- Recent history of cardiovascular event
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (1)
Huandong Hospital
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jianqin Sun, MD, MPH
Clinical Nutrition Center, Huadong Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 12, 2007
First Posted
October 15, 2007
Study Start
May 1, 2005
Last Updated
October 15, 2007
Record last verified: 2007-10